Literature DB >> 9012326

Relationships between ferruginous bodies and uncoated asbestos fibers in lung tissue.

R F Dodson1, M O'Sullivan, C J Corn.   

Abstract

Tissue was obtained from two American groups. The tissue was defined by ferruginous body levels of either < or = 1000 or > 1000 ferruginous bodies/g dry weight, and tissue was evaluated by light microscopy and analyzed by analytical transmission electron microscopy. Tissue was bleach digested, and uncoated asbestos fibers were classified with respect to type and size. In addition, some ferruginous body cores were analyzed. There was a wide range of uncoated fibers associated with each ferruginous body. A relationship was found between amosite fibers and ferruginous bodies. Other asbestos types were not associated significantly with the development of ferruginous bodies. Uncoated crocidolite fibers were not detected in these samples; this result further emphasizes the under-appreciated exposure of Americans to amosite. The levels of ferruginous bodies in both groups suggest exposures above those expected in the general population. Uncoated chrysotile levels were below the ranges reported previously for some general populations. The data suggest that there is a wide variation in the ratio of uncoated to coated fibers and that the amphibole in the United States is more likely to be amosite than crocidolite.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9012326     DOI: 10.1080/00039896.1996.9936047

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  2 in total

1.  Tyler asbestos workers: mortality experience in a cohort exposed to amosite.

Authors:  J L Levin; J W McLarty; G A Hurst; A N Smith; A L Frank
Journal:  Occup Environ Med       Date:  1998-03       Impact factor: 4.402

2.  The association among ferruginous body, uncoated fibers, asbestos and non-asbestos fibers in lung tissue in terms of length.

Authors:  Takayoshi Suzuki; Yoko Sakakibara; Naomi Hisanaga; Kiyoshi Sakai; Il-Je Yu; Hyun-Sul Lim; Hiroshige Mikamo; Hiroshi Seno; Fumio Kobayashi; Eiji Shibata
Journal:  Ind Health       Date:  2016-03-25       Impact factor: 2.179

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.